Targeting PD-L1/CMTM6 in myeloid cells results in elevated release of CCL2 to improve CD8 T cell-mediated antitumor response

被引：0
|
作者：
Hsu, Michelle Alexandria
Liu, Xin
Li, Ying
Barham, Whitney
Pavelko, Kevin
Hirdler, Jake
Lucien, Fabrice
Dong, Haidong
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-2664
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2664
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
    Miao, Beiping
    Hu, Zhaoqing
    Mezzadra, Riccardo
    Hoeijmakers, Lotte
    Fauster, Astrid
    Du, Shangce
    Yang, Zhi
    Sator-Schmitt, Melanie
    Engel, Helena
    Li, Xueshen
    Broderick, Caroline
    Jin, Guangzhi
    Gomez-Eerland, Raquel
    Rozeman, Lisette
    Lei, Xin
    Matsuo, Hitoshi
    Yang, Chen
    Hofland, Ingrid
    Peters, Dennis
    Broeks, Annegien
    Laport, Elke
    Fitz, Annika
    Zhao, Xiyue
    Mahmoud, Mohamed A. A.
    Ma, Xiujian
    Sander, Sandrine
    Liu, Hai-kun
    Cui, Guoliang
    Gan, Yu
    Wu, Wei
    Xiao, Yanling
    Heck, Albert J. R.
    Guan, Wenxian
    Lowe, Scott W.
    Horlings, Hugo M.
    Wang, Cun
    Brummelkamp, Thijn R.
    Blank, Christian U.
    Schumacher, Ton N. M.
    Sun, Chong
    CANCER CELL, 2023, 41 (10) : 1817 - +
  • [2] PD-L1 costimulation of the CD8 T cell response to Listeria monocytogenes infection
    Xu, Daqi
    Fu, Han-Hsuan
    Obar, Joshua
    Park, Jang-June
    Tamada, Koji
    Lefrancois, Leo
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [3] Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1
    Chui, Noreen Nog-Qin
    Cheu, Jacinth Wing-Sum
    Yuen, Vincent Wai-Hin
    Chiu, David Kung-Chun
    Goh, Chi-Ching
    Lee, Derek
    Zhang, Misty Shuo
    Ng, Irene Oi-Lin
    Wong, Carmen Chak-Lui
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (01) : 178 - 193
  • [4] N6-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner
    Yibing Wang
    Peng Jin
    Xia Wang
    Apoptosis, 2024, 29 : 142 - 153
  • [5] N6-methyladenosine regulator YTHDF1 represses the CD8?+?T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m6A/PD-L1 manner
    Wang, Yibing
    Jin, Peng
    Wang, Xia
    APOPTOSIS, 2024, 29 (1-2) : 142 - 153
  • [6] MAX transcriptionally enhances PD-L1 to inhibit CD8+T cell-mediated killing of lung adenocarcinoma cells
    Huang, Dongwei
    Wang, Xueni
    Qian, Yunfeng
    Wu, Jun
    Chen, Binzhuan
    Zhang, Deming
    Dong, Fengying
    Li, Yongqiang
    CELLULAR IMMUNOLOGY, 2023, 386
  • [7] Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
    Thibaudin, Marion
    Limagne, Emeric
    Hampe, Lea
    Ballot, Elise
    Truntzer, Caroline
    Ghiringhelli, Francois
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (10) : 2549 - 2563
  • [8] Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer
    Marion Thibaudin
    Emeric Limagne
    Léa Hampe
    Elise Ballot
    Caroline Truntzer
    Francois Ghiringhelli
    Cancer Immunology, Immunotherapy, 2022, 71 : 2549 - 2563
  • [9] Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cells
    Leng, Changsen
    Li, Yin
    Qin, Jianjun
    Ma, Jun
    Liu, Xianben
    Cui, Yingying
    Sun, Haibo
    Wang, Zongfei
    Huai, Xionghuai
    Yui, Yongkui
    Li, Haomiao
    Zhang, Jun
    Zheng, Yan
    Wang, Wei
    Zhui, Jijnwei
    Wang, Qiuming
    ONCOLOGY REPORTS, 2016, 35 (02) : 699 - 708
  • [10] DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8 T cells independently of PD-1 and PD-L1
    Mukherjee, Gayatri
    Geliebter, Ari
    Babad, Jeffrey
    Santamaria, Pere
    Serreze, David V.
    Freeman, Gordon J.
    Tarbell, Kristin V.
    Sharpe, Arlene
    DiLorenzo, Teresa P.
    INTERNATIONAL IMMUNOLOGY, 2013, 25 (11) : 651 - 660
12345